LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC.

LABT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Jun 2025 Mar 2025 Dec 2024
Assets
Cash & Equivalents $2.6M $11.7K $236.4K $1.3M $477.0K $681.1K
Accounts Receivable
Inventory
Total Current Assets $4.8M $50.6K $305.4K
Property, Plant & Equipment $6.9K $8.1K $9.2K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $5.0M $196.3K $481.6K
Liabilities
Accounts Payable $165.9K $547.8K $381.0K
Total Current Liabilities $628.9K $3.0M $2.4M
Long-Term Debt
Total Liabilities $628.9K $3.0M $2.4M
Stockholders' Equity
Retained Earnings $-68.6M $-54.3M $-53.4M
Total Stockholders' Equity $4.3M $-2.8M $-2.0M $-683.3K $-76.2K $409.6K